1. Past and present of diagnostic electron microscopy
=====================================================

Knowledge, expertise and capabilities depend on the available detection methods as clearly exemplified by Robert Koch's achievements in bacteriology. When systematically applying light microscopic techniques to search for and identify pathogens in the second half of the 19th century, Koch soon succeeded in describing precisely a number of medically important agents, e.g. *Bacillus anthracis* in 1876*, Mycobacterium tuberculosis* in 1882, and *Vibrio cholerae* in 1883 ([@BIB52], [@BIB53], [@BIB54]). But, like others, he experienced the limits of light microscopy when studying what we know today as viral diseases. Fulfilling Ernst Abbe's early prophecies ([@BIB1]), demonstrating sub-lightmicroscopic, ultrafiltrable agents only became possible with the construction of an entirely new type of microscope using monochromatic accelerated electrons instead of visible light for imaging ([@BIB51], [@BIB69], [@BIB100], for historical reviews see c.f. [@BIB92], [@BIB37]).

Technical development culminated in the late 1930s when EM with its inherently higher resolution became irreplaceable in characterizing submicroscopic structures. Previous research on virus particles depended mainly on indirect analysis, e.g. filtration and sedimentation. By applying EM, virology made a great step forward, as it allowed the direct demonstration of the particulate nature of viruses as well as the description of their size and morphology, shown already by the first electron micrographs of poxviruses ([@BIB102]). Within a short period of time a number of additional viruses and bacteriophages, as well as bacteria, were morphologically characterized ([@BIB46], [@BIB89], [@BIB90], [@BIB91], [@BIB59]) making insights into structure-function relations and classification of viruses possible. Immune EM techniques were also developed very early, based on specific antibodies as part of the preparative and analytical repertoire ([@BIB5], [@BIB101]).

The value of EM in viral diagnosis soon became apparent. Although lacking today's contrast techniques, the early osmium smoking methods allowed the differentiation between the chickenpox herpesvirus and the brick-shaped smallpox virus directly from the patients' vesicle fluid ([@BIB77], [@BIB98], [@BIB84]; see c.f. [Fig. 1](#FIG1){ref-type="fig"} ). Heavy metal shadowing techniques, developed soon afterwards, permitted particle counting and the morphological assessment of purified virus and were of great scientific value ([@BIB103]). In virus diagnosis, however, shadowing often obscured viral structures because of the debris usually present in diagnostic specimens. The advent in the 1960s of both the negative staining techniques ([@BIB13]; for review see [@BIB38], [@BIB12], [@BIB36]) and easy-to-handle instruments encouraged a broad application of EM to routine viral diagnosis. In the following years, a great number of clinically important, previously undescribed agents, e.g. adeno-, entero-, myxo-, paramyxo-, and reoviruses, was identified, mostly from diagnostic cell cultures. By extensive sero-epidemiological and virus neutralization studies these isolates could be linked etiologically to respective disease. Scrutinized by EM, many of them were recognized as 'new' and morphologically distinct viruses. The differences observed in morphology were used as the criteria for virus classification ([@BIB96]).Fig. 1Direct EM of (a) herpesvirus particles from a varicella vesicle and (b) parapoxvirus recovered from the skin ulcers of a diseased seal, demonstrating the principles of morphological diagnosis after negative staining and the advantages of using different stains. The membrane destroying and/or penetrating effect of 2% phosphotungstic acid helps to reveal the 100 nm herpesvirus capsid within the viral envelope. 1% uranyl acetate on the other hand, by its remarkable membrane stabilizing effects, reveals the surface detail of the brick-shaped poxvirus very clearly. Magnification, ×80 000; bar, 100 nm.

In a number of clinically important diseases, however, e.g. hepatitis and non-bacterial gastroenteritis, cell culture isolation techniques failed to discover the causative agents. Though the transmissibility of a disease was clearly shown, some through the use of volunteers experiments ([@BIB88]), sometimes without clear consent ([@BIB55]), the presumed viral agents turned out to be non-cultivable. The hunt for these \'fastidious' agents went on for more than two decades and became successful only when direct EM was utilized in the 1970s to study also 'dirty' specimens like plasma, urine, feces (for overview see c.f. [@BIB4], [@BIB63], [@BIB66]). Hepatitis B and A viruses were then detected in plasma and stool specimens respectively ([@BIB19], [@BIB23]). In the next few years several etiological agents linked to gastroenteritis were discovered: Using direct EM, rotaviruses were found to be a major cause of endemic acute gastroenteritis in animals and humans ([@BIB11], [@BIB25], [@BIB7]; for review see [@BIB43]). Investigating a recent outbreak of diarrhea and vomiting at Norwalk, Ohio, Kapikian and colleagues detected small, round particles by immune aggregation and linked those structures to the outbreak ([@BIB42]). The capsids of Norwalk and Norwalk-like viruses display only weak surface details ([Fig. 2](#FIG2){ref-type="fig"} c), based on their nucleic acid composition, however, they are classified today as members of the *Caliciviridae* ([@BIB74], [@BIB15], [@BIB44], [@BIB71]). Astroviruses were described ([@BIB61], [@BIB64]) as causes of endemic gastroenteritis in humans; later they were also found as common pathogens in poultry and mammals (review see c.f. [@BIB70]). Also particles morphologically resembling the earlier described animal caliciviruses, i.e. showing the deep cup-shaped holes on the capsid ([Fig. 2](#FIG2){ref-type="fig"}a), have been linked to cases of human diarrhea and vomiting ([@BIB26], [@BIB62], [@BIB99], [@BIB104]; for review see c.f. [@BIB44]). Due to the lack of molecularly-based diagnostic tests, the majority of these uncultivable small spherical particles were tentatively assigned to one of two morphologically-defined groups ([@BIB14]): either small round structured viruses (SRSV; [Fig. 2](#FIG2){ref-type="fig"}) comprising the astro-, calici-, and Norwalk/Norwalk-like viruses, or to small round non-structured viruses (SRNSV), including the *Parvo- or Picornaviridae*, e.g. polio or coxsackie viruses, displaying a smooth capsid structure.Fig. 2Overview of the morphology of small round viruses, known to be causative agents of gastroenteritis. (a) calicivirus, named according to the very distinct capsid morphology with 32 deep surface indentations (Greek 'calix', cup, goblet). (b) astrovirus with their typical, star-like capsid symmetry (Greek 'aster', star). (c) Norwalk virus, barely displaying any surface detail, named after the place, where the first outbreak caused by this virus was described. (a)--(c) Negative staining using 1% uranyl acetate. Magnification, ×80 000; bar, 100 nm.

Because of its inherent quantitative and economical limitations, however, EM is not suited for a mass screening of clinical specimens. Therefore, in the following years a number of alternative tests were developed. Today, for many of the 'new' viruses ELISAs and/or molecular-genetic techniques are available to detect viral antigen, antiviral antibodies, or nucleic acids. These techniques have taken over much of the diagnostic EM's previous burden, although they are not a real substitute for and therefore not comparative to EM diagnosis: their objective, e.g. viral antigen or nucleic acids, or antiviral antibodies, differs from that of EM, the virus particle itself.

In conclusion, looking back at the history of diagnostic EM, a dramatic change of paradigms can be seen: During the early phase, EM viral diagnosis was confined mainly to differentiating smallpox from other viruses present in vesicle fluids of skin lesions ([@BIB77], [@BIB98], [@BIB84], [@BIB76], [@BIB17], [@BIB58]). During the second phase, so far the broadest application of EM in viral diagnosis, many new viruses were described. When electron microscopists in the 1970s also learned to study body excretous ([Fig. 3](#FIG3){ref-type="fig"} ), a number of 'new' etiological agents was discovered with many of them being diagnosed exclusively by EM (for review see [@BIB68], [@BIB66]). The approach of direct EM was successful because many of these viruses, e.g. rota-, astro-, and parvoviruses are shed in high concentrations, often reaching particle concentrations of 10^11^ ml^−1^. The third phase finally is characterized by a marked reduction of laboratories performing diagnostic EM. Following the rapid development of modern test systems based on both molecular biology and genetics, the use of diagnostic EM has gone out of fashion. This loss of its use as a standard tool in viral diagnosis is more evident in human medicine, while the veterinarians are still thinking of EM as an universal, and therefore not too expensive, diagnostic tool. As a result of this decline in use, the quality of diagnostic EM laboratories lacking the daily routine is often decreased, resulting in further reductions in its use. To assess the future role of EM in viral diagnosis we would like to ask a number of questions, and without satisfactory answers to these questions, the future of EM as a constituent of the viral diagnostic armament appears dim.Fig. 3Human polyomavirus from the urine of bone marrow transplant recipients. (a) Negative staining after ultracentrifuge enrichment (100 000 ×*g*, 1 h, 20°C) using 1% uranyl acetate. (b) Thin section EM of a sediment (see a) embedded in Epon showing an immune aggregate. (c) Thin section EM of diagnostic HEL cell cultures inoculated with urine after ultracentrifuge enrichment. A paracrystalline array of polyoma virus particles is displayed. Magnification, ×80 000; bar, 100 nm.

2. What are the specific benefits of EM in viral diagnosis compared to the alternatives?
========================================================================================

Many direct and indirect techniques are in use for detecting virus in clinical specimens. Differing in their objectives and their principles, their efficiencies must be compared with caution, e.g. one infectious unit detectable in cell culture might be equivalent to 10--10 000 'physical' particles detectable by visualization, depending on the particle:infectivity ratio ([Table 1](#TBL1){ref-type="table"} ). It is generally agreed that diagnostic EM with its rapid preparation and evaluation permits a very quick diagnosis ([@BIB28], [@BIB4]). Another principal advantage compared to alternative test systems is the undirected 'open view' making this technique a 'catch-all' method: using diagnostic EM no prior selection of which virus to be sought is made or is necessary, enabling the detection of even unexpected viral structures ([@BIB66], [@BIB9]). The current ICTV classification describes 75 virus families ([@BIB74]) with 25 and 21 families representing vertebrate and human viruses, respectively. Because the virions of each of the 25 families of animal viruses display distinct morphologies, the particles can be assessed according to size and fine structure and grouped to one specific family out of the 25 a priori by the ICTV defined taxons. Assignment to a particular virus family often fulfills the immediate needs of the clinician. Thus, the present system of virus taxonomy justifies a morphology-based diagnosis. Several excellent atlases and textbooks on the fine structure of viruses and aspects of EM diagnostic virology present detailed information on the structural peculiarities and distinctive criteria ([@BIB21], [@BIB65], [@BIB82], [@BIB83], [@BIB78]).Table 1Comparison of different techniques for virus detectionTechniqueDetection ofSensitivitySpecificitySpeedMultiplex assays availableNucleic acid amplification (NAT)Viral genome, i.e. parts of itHigh (10--50 molecules per assay)Type/group/family1--4 hYes (usually for different types or groups of the same family)Cell culture detectionInfectivity and cytopathityHigh (1 infectious particle per assay)Group/family2--14 dYes for cytopathic virusesElectron microscopy Immune EM TypeVirus particlesLow (\>10^7^ mL^−1^) intermediate (\>10^4^--10^5^mL^−1^)Group/family15 min 120--240 minBy virtue of its 'open view' it is a 'catch-all-method'ELISAViral antigen or specific antibodiesIntermediateType/group2--3 hNoImmune light microscopy (immune fluorescence, APAAP)Viral antigen or specific antibodiesHighType/group2--3 hYes

The benefits and limitations, e.g. the 'open view' and rapidity of the individual EM diagnosis on the one hand and the need for high particle concentrations resulting in relatively low sensitivity of diagnostic EM on the other hand have been discussed in many reports ([@BIB28], [@BIB39], [@BIB3], [@BIB49], [@BIB24], [@BIB4], [@BIB27], [@BIB83], [@BIB72], [@BIB31], [@BIB68], [@BIB56], [@BIB16], [@BIB66], [@BIB8]). Today, the benefits of diagnostic EM can range from null to remarkably high, depending on the diagnostic problem itself. The performance of diagnostic EM, however, depends on a number of technical and methodological factors.

3. Methods used in diagnostic EM
================================

If one decides to apply EM viral diagnosis, there are a number of methods available. So, what recommendation should be given to a beginner in diagnostic EM? Generally, a transmission EM is used, and the preparative technique most often applied is negative staining (for review see [@BIB10]). Thin section EM, however, is essential in the further characterization of a virus, e.g. the elucidation of its interaction with the host cell. The instrument used should not necessarily be highly sophisticated, it should allow stable primary routine magnifications of 40 000× to assess fine structural detail and also have data recording means, e.g. a sheet film or digital camera.

Using negative staining, direct EM as the most simple approach should be used. It will allow assessment of the specimen quality and indicate whether enrichment techniques should be used. Immune EM (IEM) may then be applied, if necessary. Several prerequisites for the efficient performance of diagnostic EM are:

\(1\) The use of stable, hydrophilic carbon-coated grids leads to a an efficient and stable adsorption of particles and a suitable stain distribution on the grid. Hydrophilicity can be achieved by pretreatment of the grids with polycations ([@BIB60]; for details see c.f. [@BIB10]) or by a glow discharge ([@BIB2], [@BIB12], [@BIB36]).

\(2\) The parallel application of two negative stains with different staining features, e.g. aqueous solutions of uranyl acetate and phosphotungstic acid, might help to visualize difficult-to-assess structures more convincingly, in particular with unfamiliar specimens ([@BIB10]).

\(3\) To increase the concentration of virus particles on the grid, i.e. to lower the detection limit, three principal enrichment techniques are available: agar filtration, sedimentation, and bioaffinity techniques; being part of our diagnostic repertoire they are listed with their respective enrichment factors in [Table 2](#TBL2){ref-type="table"} .Table 2Key data of different particle enrichment techniques for negative staining EMTechniqueParticle enrichment factorParticle recovery on grid (%)Minimal particle concentrationTime required for preparation (min)Evaluation MethodConventional direct EM=10.01--0.5010^7^ ml^−1^5--10Measurement of radioactive-labeled virusesAgar filtration3--70.08--1.105×10^6^ ml^−1^15--30Airfuge^®^ sedimentation10--1001.02--5.6010^5^ ml^−1^10--20Ultracentrifuge sedimentation50--100n.d.10^5^ ml^−1^60--120Comparative particle countingSPIEM10--100n.d.10^5^ ml^−1^30--120SPIEM+ultra-centrifugation100--800n.d.10^4^ ml^−1^90--240

*Agarfiltration* initially was introduced for particle counting in EM ([@BIB47]): while giving cleaner specimens, filtration also enriches particles by a factor of 3--7. Likewise, the pseudoreplica technique leads to an appreciable enrichment (for details see c.f. [@BIB38]). *Ultracentrifugation* permits the sedimentation of virus particles from a large suspension volume into a small sediment, following a preceding low-speed centrifugation for debris removal, if necessary. By resuspending the pellet in a small volume, the virus is concentrated 50--100-fold. Alternatively, particles may be sedimented directly onto the grid using the Airfuge® technique, resulting in similar enrichment factors ([@BIB30], [@BIB35]).

*Bioaffinity methods* or IEM mainly relies on high-affinity virus-specific antibodies or other specific ligands, e.g. lectins, that may be used in different ways. Using hyper-immune sera directed against a specific virus or paired (acute and reconvalescent) sera, the etiologic role of the agent can be demonstrated by immune-aggregation or -decoration. Early, immune-aggregation was used to clump individual virus particles into larger immune complexes that can be easier detected than individual particles scattered in dilute suspensions ([@BIB5], [@BIB101]). Thus, polyclonal sera are useful in increasing the detectability of dispersed virus particles, while monospecific antibodies help for both, immune-aggregation-enrichment and serotyping by immune-decoration.

The IEM approach can be very successful, as recently exemplified by the delineation of at least nine different serotypes of SRSV ([@BIB81]) or three serotypes of Norwalk-like viruses ([@BIB57]), respectively. As well as direct IEM techniques, indirect immuno-aggregation techniques have also been developed, using species specific anti-IgG antibodies or protein A in addition to enrich, to label, and to type antibody-coated viruses ([@BIB97], [@BIB45]).

The most sensitive IEM technique in viral diagnosis is solid phase IEM (SPIEM). Here the specific antibody is bound to the grid and, in a second step, the virus is captured immuno-specifically from the diagnostic suspension. This approach, also known as the 'fly-paper' technique and first developed for plant virus quantification ([@BIB20]) was soon applied also to diagnostic specimens. The sensitivity was further improved by the introduction of protein A as to bind antibody to the grid ([@BIB94], [@BIB79]), and widely applied to clinical specimens ([@BIB50], [@BIB32], [@BIB33], [@BIB40], [@BIB57]). SPIEM reaches a sensitivity comparable to the equivalent ELISA systems ([@BIB50], [@BIB95], [@BIB33]). Remarkably, it has also been experienced, that even direct EM can reach the sensitivity of commercial ELISAs ([@BIB73], [@BIB18]).

Using SPIEM, the sensitivity of diagnostic EM is improved up to 100 times ([@BIB50]) and reaches detection limits down to values of e.g. 10^2^--10^3^ plaque forming units per milliliter ([@BIB34]). Compared to nucleic acid amplification techniques (NAT) for SRSVs neither SPIEM nor NAT detect every virus-positive specimen---however, they complement each other ([@BIB41], [@BIB18]).

\(4\) In general, the use of routine laboratory and reporting protocols following GLP rules is highly recommended (for details see [Table 3](#TBL3){ref-type="table"} ).Table 3GLP requirements for diagnostic EMLab organizationTechnical facilitiesLab is part of a diagnostic network with efficient informational exchange (e.g. public health network or big clinic)Working facilities according to safety regulations  Regularly trained personnelElectron microscope with appropriate primary magnification  Data recording systemLow speed centrifuge for clearing  Controlled lab data flowUltracentrifuge for enrichmentStable highly adsorptive gridsDifferent contrasting 'stains'Panel of high affinity antibodies directed against diagnostic relevant viruses

4. What are the actual indications for EM viral diagnosis?
==========================================================

A morphological diagnosis uncovers the implicated virus family and often fulfills the clinician's immediate needs, saving precious time and complex diagnostic efforts. If a complete diagnosis to the specific serotype is required, an early morphological diagnosis will focus the diagnostic efforts onto the relevant virus family, thus again saving diagnostic efforts. Therefore, the decision to utilize EM must be made early in the diagnostic procedure, in parallel or even before routine cell culture inoculations (e.g. the need for rapid viral diagnosis in suspected varicella in a newborn ward or an immuno-compromised patient).

As with other diagnostic means, EM viral diagnosis is not possible in all cases, mainly because the agent possibly involved may vary in its detectability for both quantitative and qualitative reasons. This is exemplified by two recent outbreaks of emergent diseases, e.g. Hantavirus Pulmonary Syndrome (HPS) in the USA in 1993, also known as 'Four Corner's Disease' ([@BIB22], [@BIB48]) and the paramyxovirus infections killing horses and humans and caused by a 'new' morbillivirus in Australia in 1995 ([@BIB75]). EM was of no help in the direct elucidation of HPS for two reasons: First, the causative agent, a member of the Bunyaviridae, is present only in low concentration in specimens taken directly from the patient or in diagnostic cell cultures. Second, the morphology of the bunyavirus particles is not so distinctive in diagnostic cell culture supernatants to allow a clear-cut and reliable morphological diagnosis.

The situation was different in the elucidation of the equine morbillivirus: negative staining EM of infected diagnostic cell cultures soon revealed typical ribonucleoprotein strands pointing towards a paramyxovirus. This helped to guide more targeted diagnostic efforts three days before any other specific results were available ([@BIB80]). In the field of emerging virus diseases, diagnosis of filovirus infections will also benefit from EM ([Fig. 4](#FIG4){ref-type="fig"} ; [@BIB29], [@BIB93]; for review see c.f. [@BIB6]).Fig. 4Negative staining of purified cell culture isolates from (a) Ebola virus and (b) Marburg virus. The filamentous structures of Ebola virus generally longer than those shown by Marburg virus. Magnification, ×20 000; bar, 1000 nm.

Arguing, with today's financial limitations, EM is driven out of many laboratories, and EM viral diagnosis often is only confined to infections with more severe clinical or epidemiological implications. Under suitable circumstances, however---assuming an efficient laboratory organization---EM viral diagnosis can be cost-effective also today ([@BIB18]): the main cost is buying the instrument in the first place, although it is no more expensive, even new, than some of the sophisticated autoanalysers. Given the microscope, the only other major expense is the microscopist, who can be a senior technician provided there is a proper back-up; the consumables are not important in comparison. If the running expenses are low, EM should be used as much as possible, thus keeping pattern recognition capabilities of the microscopists high and the costs per specimen as low as possible. In addition, spending all the time on what is left over in clinical virology as 'difficult' specimens is worrying to the microscopists---the simpler specimens often do not reach the EM. Looking at these calculations, EM properly used is not more expensive than the other techniques, test for test ([@BIB67]).

In conclusion, if EM diagnostic facilities are run by experienced personnel using state-of-the-art techniques, the possible benefits in viral diagnosis are evident. EM is essential in epidemiological or clinical conditions when a rapid viral diagnosis is required for instant clinical reasons, to abbreviate cell culture diagnosis, and/or when alternative standard diagnostic methods fail to produce reasonable results. In particular it is important as an instrument in the rapid viral diagnosis of suspected emerging virus infections ([Table 4](#TBL4){ref-type="table"} ). A broader application of routine EM diagnosis is often confined to certain clinical syndromes, e.g. the elucidation of epidemic and endemic gastroenteritis.Table 4Indications for the use of diagnostic EMIndicationExampleRapid viral diagnosisCritical epidemiological or clinical conditions, e.g. suspect of emerging viral diseases or need for fast diagnosis in immuno-compromised individuals  Abbreviation of classical cell culture diagnosisUnknown CPE  Search for unknown or undetectable virusesFailure or lack of other diagnostic techniques  Need for 'catch-all-method'Lack of clinical data or broad group of suspected agents (e.g. in diarrhea)  Quality control in industrial processesFollowing GMP rules in the production of biologicals, e.g. search for contaminants in cell culture based vaccine production

5. Requirements for future EM diagnosis---how can the EM diagnostic labratory be prepared for the future?
=========================================================================================================

As diagnostic virology in general becomes more controlled and standardized, only accredited laboratories will be permitted in the near future to provide any diagnostic services within the public health framework. This development leaves two alternatives: either (1) radically stopping EM-diagnosis as a tool in clinical virology or (2) to join a system of assessment and evaluation provided by national and/or international EQA schemes. These schemes will help diagnostic EM to retain high standards and to accredit them by developing standards for EM quality assurance and control.

Besides appropriate technical facilities and methods, effective organization and continuing educational efforts are required, i.e. the general implementation of GMP rules. External quality control of EM diagnosis is important for a reliable test service, which on the other hand, also determines the future of diagnostic EM. Regular participation in well designed external quality assurance programs is required for accreditation as a diagnostic facility. The first European External Quality Assurance Program (EQA) was started in 1967 by the Public Health Laboratory Services (PHLS) in Great Britain, including both serological and virus isolation procedures ([@BIB86]). Later, in 1977, the PHLS also set up an EQA for EM viral diagnosis ([@BIB87]). However, this program after 20 distributions was stopped in 1993. To our knowledge, no other EQA for EM diagnosis was available until our program started in 1994. Its aim is to evaluate, to monitor and to improve the quality of diagnostic EM. It is run within the framework of, and supported by, a number of national and international societies, e.g. European Society for Clinical Virology (ESCV), European Society for Veterinary Virology (ESVV), German Society for Electron Microscopy (Deutsche Gesellschaft für Elektronenmikroskopie, DGE), German Society for Hygiene and Microbiology (Deutsche Gesellschaft für Hygiene und Mikrobiologie, DGHM), German Society against Viral Diseases (Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten, DVV), Virological Society (Gesellschaft für Virologie, GfV).

EQA-EMV is run twice a year and is open to all laboratories working in the framework of viral diagnosis ([@BIB85], [@BIB9]). Two different types of coded specimen are sent out: (a) ready-made specimens (Pioloform coated, carbon reinforced copper grids 300/400 mesh, diameter 3.02 mm; uranyl acetate negative staining) and (b) inactivated and stabilized virus particle suspensions (0.1 ml; formaldehyde 4%, sodium azide 0.02%). Further information can be obtained from the internet at http://www.rki.de/INFEKT/EMQM/EM_MAIN.HTM.

In the first two runs, purified virus was used to prepare the test specimens to assess the diagnostic skills of the participants. The distribution of more realistic, i.e. more 'clinical' specimens started with EQA 3. From EQA 4 onwards the specimens have been distributed all over Europe and, since EQA 6 this has been worldwide ([Fig. 5](#FIG5){ref-type="fig"} ). Beginning with the sixth distribution, the participants results have been compared with a standard set tested by six selected reference laboratories and representing the 100% correct standard results. The participants are informed of their individual and on the cumulative results and, if required, may receive also a certificate of participation.Fig. 5EQA map showing the participating countries in EQA 7 (distributed in February 1999) highlighted in dark gray. The development of the numbers of participants and participating countries, respectively, are shown in the lower left.

The participants are physicians and veterinarians as well as biologists, working in public health services, governmental institutions, universities, industry, at the army; the number of participants has risen from 28 German laboratories to 78 institutions in 20 countries ([Fig. 5](#FIG5){ref-type="fig"}).

The main emphases of this EQA program are twofold: (1) training the participants' diagnostic skills, especially the 'open view', and (2) with the stabilized virus suspensions, controlling the efficiency of specimen preparation. Other helpful aspects are: being confronted with rare and/or diagnostically difficult viruses, and, finally, because specimens containing dual infections and negative controls are also sent out, the participants learn to follow standard protocols for screening specimens with EM, e.g. screening for defined periods.

The results of EQA 1--6 can be summarized as follows:1.Though in some countries the number of laboratories performing EM viral diagnosis is still diminishing, there is a considerable number of participants and participating countries ([Fig. 5](#FIG5){ref-type="fig"}). These data confirm a need for this program.2.The efficiency of diagnostic EM depends clearly on virus concentration and purity. Some participants have had problems in differentiating between paramyxo- and orthomyxovirus, polyoma- and papillomavirus, reo- and rotavirus, coronavirus and 'normal' constituents, as well as SRS(N)Vs and normal constituents. 'Dual infections' with widely different particle concentrations are not always detected. However, the educational value of EQA are obvious, as shown by the overall performance index rising as well as the indices for the more problematic viruses ([Table 5](#TBL5){ref-type="table"} ). To retain the capacity and a reasonable good expertise in EM virus diagnosis for future diagnostic needs, regular quality control regimes and educational efforts are necessary. These measures will help to keep EM viral diagnostics within the 'modern' diagnostic laboratory.Table 5Summary of EQA 1-6, showing the overall performance as well as for selected virusesEQA NoNumber of participantsGridsSuspensionsOverall (%)Paramyxo (%)Adeno (%)Rota (%)Dual infections (%)Overall (%)Paramyxo (%)Adeno (%)Herpes (%)Dual infections (%)Purified viruses at high particle concentrations12882298996------------2289893------55----96--'Dirty' specimens with more realistic particle concentrations33447----2824----------4356134100100295520718017549779010096--613192842965677--93--297127958925
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